FOR IMMEDIATE RELEASE
March 17, 2016
Senate Special Committee on Aging Examines Drug Pricing
Ahead of this morning’s Senate Special Committee on Aging hearing on drug pricing, John Rother, executive director of the Campaign for Sustainable Rx Pricing issued the following statement:
“Today’s hearing shows that fighting high prescription drug prices is truly a bipartisan battle. Companies are buying decades-old prescription drugs and jacking up prices on vulnerable patients. It’s unconscionable. We need more transparency and competition in the prescription drug market to protect Americans from this appalling practice.”
And, the problem of rising prescription drug prices is even more widespread than just Turing Pharmaceuticals or a few bad actors. Learn more about the startling pace of across-the-board price increases here in our fact sheet.